Ingredient deep-dive

3,000 mg: The Ginseng Dose Almost Every Trial Used

Panax ginseng is the best-evidenced botanical in this whole category and it is also the one whose evidence is most often quoted without its dose. Every positive trial named a number. Not one of those numbers was small, and the gap between them and a blend capsule is the single most useful thing a buyer can know.

By HoneyPower Team · Medically reviewed by Dr. Sevann Helo, MD · Revised September 30, 2026 · 9 min read · Ingredient deep-dive

What the Cochrane review actually says

the 2021 Cochrane review is the most authoritative single document on this question. It pooled nine randomised trials covering 587 men and reported that ginseng improved erectile function scores compared with placebo.

That is a positive finding and it deserves to be reported as one. What deserves equal billing is the certainty rating the reviewers attached to it, which was low. The included studies were small, several were poorly reported, and the review authors were explicit about both.

A low-certainty positive result is not nothing. It is a reason to take an ingredient seriously and a reason to be modest about how much weight it can carry. Both halves of that sentence come from the same document.

The doses, trial by trial

The reason a dose table is more useful than a summary is that the summary travels and the doses do not. Here is what the individual trials behind that review actually ran.

Four trials, four different preparations of the same plant, and four different doses. The last row is the only one that tested two doses against each other.

the Sao Paulo trial at 3,000 mg a day is the study most often pointed at, and it ran at three grams a day of Korean red ginseng for twelve weeks in men with erectile dysfunction. a 143-man trial at 2,000 mg a day ran two grams a day of a tissue-cultured mountain ginseng extract in 143 men over eight weeks. the ginseng berry study at 1,400 mg a day ran 1.4 grams a day of a berry extract across multiple centres.

The smallest of those three is 1,400 mg a day of a single ingredient. That figure alone would fill two large capsules with nothing else in them.

One species name, five different ingredients

There is a second problem hiding inside the first, and it is the one that catches careful readers out. Panax ginseng is a species. It is not an ingredient specification, and the trials above did not all test the same material.

Five materials, one species name. A label that prints only the species has told you the plant and not the ingredient.

Red ginseng is steamed before drying, which alters its ginsenoside profile enough that the pharmacology textbooks treat it separately from white ginseng. Berry extract comes from the fruit rather than the root and has its own compound profile. Tissue-cultured extract is grown rather than harvested.

So a label printing Panax ginseng and stopping there has identified the plant and left the ingredient open. A label printing Korean red ginseng standardised to a stated ginsenoside percentage, at a stated weight, has told you something you can compare against a trial. The distance between those two labels is large.

The trial that separated a big dose from a small one

a 12-week exercise trial that separated 500 mg from 100 mg is unusual and useful. Rather than testing one dose against placebo, it ran a high-dose ginsenoside complex against a much smaller one over twelve weeks in healthy adults following a supervised exercise programme, with physical performance as the endpoint.

The larger dose produced a measurable improvement. The smaller one did not. That is a threshold, demonstrated inside a single trial rather than inferred by comparing two separate studies, and thresholds are exactly what a buyer holding a capsule needs.

It also gives a rough sense of where the floor sits. The comparison in that study was five hundred milligrams against one hundred, of a concentrated ginsenoside preparation rather than whole root, and the hundred did nothing measurable.

What ginseng did not do

The commonest misreading of ginseng in this aisle is hormonal, and it is worth correcting directly. the one hormone trial at 3 g a day gave three grams a day to men with metabolic syndrome and measured reproductive hormones alongside mitochondrial DNA copy number. Testosterone did not change.

Whatever the mechanism behind the erectile-function findings is, it is not a testosterone effect. That matters because a great deal of marketing in this category runs the two together, and a reader who buys ginseng expecting a hormone change is buying it for a reason the research does not support.

The interaction worth knowing before you start

the warfarin trial is a randomised controlled trial in healthy volunteers that measured what happened to warfarin's anticoagulant effect when ginseng was added. The effect was reduced.

That is a real, measured, clinically meaningful interaction rather than a theoretical one, and anybody taking warfarin has a specific reason to raise a ginseng-containing supplement with whoever manages their anticoagulation before starting it. Naming the interaction once, precisely, is more use than a general caution repeated on every page.

What this means inside a six-ingredient capsule

Put the two constraints together. The trials ran between 1,400 mg and 3,000 mg a day of a specified ginseng preparation. A two-capsule daily serving holds somewhere around 1,400 mg of powder in total if both capsules are large ones.

So even a capsule that was entirely ginseng, with none of the other five ingredients in it, would sit at the very bottom of the range the trials used. Divided six ways, it is not in the same conversation.

There is a fair objection to that arithmetic and it deserves an answer. Concentrated extracts exist: a 10:1 extract delivers the constituents of ten times its weight in raw root, and the performance trial above used a concentrated ginsenoside complex at 500 mg rather than whole root at three grams. A label that printed a standardisation could argue this properly. A label that prints only a species name cannot, because there is no figure on it to argue from.

Four questions worth asking of any ginseng row

1. Which ginseng? Red, white, berry or tissue-cultured. The species name alone does not answer it.
2. Standardised to what? A ginsenoside percentage turns a weight into something comparable with a trial.
3. How much? The trials ran at 1,400 to 3,000 mg a day of specified material. Anything well below that needs a standardisation to justify itself.
4. Am I on warfarin or another anticoagulant? If so, this is the ingredient to raise before the first capsule rather than after it.

References